| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 8 |
| 1 | LENALIDOMIDE | 6 |
| 2 | PREDNISONE | 5 |
| 3 | INFLIXIMAB | 4 |
| 4 | INTERFERON BETA-1A | 4 |
| 5 | DEXAMETHASONE | 3 |
| 6 | DEXAMETHASONE 1.5 MG | 3 |
| 7 | ERGOCALCIFEROL | 3 |
| 8 | LISINOPRIL | 3 |
| 9 | OXALIPLATIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIPRASIDONE | 1 | 0.0003 |
| 1 | LUBIPROSTONE | 2 | 0.0002 |
| 2 | LUTETIUM LU 177 DOTATATE | 1 | 0.0002 |
| 3 | TOLTERODINE TARTRATE | 1 | 0.0001 |
| 4 | ERGOCALCIFEROL | 3 | 0.0001 |
| 5 | GOLIMUMAB | 1 | 0.0001 |
| 6 | KETOPROFEN | 1 | 0.0001 |
| 7 | ZIPRASIDONE MESYLATE | 1 | 0.0001 |
| 8 | EZETIMIBE AND SIMVASTATIN | 1 | 0.0001 |
| 9 | MERCAPTOPURINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 8 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 2 | Thalidomide Analog [EPC] | 6 |
| 3 | Benzodiazepine [EPC] | 5 |
| 4 | Interferon beta [EPC] | 4 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 6 | Estrogen [EPC] | 3 |
| 7 | Integrin Receptor Antagonist [EPC] | 3 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 9 | Osmotic Laxative [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Progesterone [EPC] | 1 | 0.0000 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 2 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 5 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Interferon beta [EPC] | 4 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |